Arthur Kuan
Chief Executive Officer at CG Oncology Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2024
3 years of board service in total across 1 board, counting each seat separately. Longest: CG Oncology Inc., 2 years.
Chief executive roles
Outstanding · grade A+
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 20% of the scoring weight is on file.
- Revenue growth 20%
- 100
345% a year in revenue
20% of the scoring weight is on file. Figures cover December 2023 – December 2025.
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 12, 2026 | CG Oncology Inc. | Option exercise | +64,612 | $1.72 | $111,133 |
| Mar 12, 2026 | CG Oncology Inc. | Shares withheld for tax | −1,847 | $60.15 | $111,097 |
| Mar 4, 2026 | CG Oncology Inc. | Option exercise | +102,871 | $1.72 | $176,938 |
| Mar 4, 2026 | CG Oncology Inc. | Shares withheld for tax | −2,871 | $61.61 | $176,882 |
Questions about Arthur Kuan
What boards is Arthur Kuan on?
Arthur Kuan sits on the board of CG Oncology Inc.
What company is Arthur Kuan the CEO of?
Arthur Kuan has been Chief Executive Officer of CG Oncology Inc. since January 2024.
How long has Arthur Kuan served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2024.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.